
Affordable glaucoma treatment breakthrough
A device developed by young Indonesian ophthalmologist Dr Virna Oktariana alongside Western Australia’s Lions Eye Institute (LEI) will make glaucoma treatment more accessible in Indonesia.Launched at

A device developed by young Indonesian ophthalmologist Dr Virna Oktariana alongside Western Australia’s Lions Eye Institute (LEI) will make glaucoma treatment more accessible in Indonesia.Launched at

It may sound a challenge akin to patting your head and rubbing your belly, but neuroscientists at Duke University have discovered that your ears move when your eyes do.Even without sound, the eardrums

‘Autofocals’ developed at Stanford University allow wearers to maintain sharp near and far focus, offering a smartglasses solution to existing bifocal, varifocal and progressive lenses.Researcher

Glasses prescribed to young children to correct hyperopia failed to show significant visions benefit after three years of follow-up in a randomised trial in the US.The Ohio State University study lead

A US study showed increased physical activity slowed rates of visual field loss in patients with glaucoma.Patients who took an additional 5000 daily steps or 2.6 hours of physical activity decreased

Guardion Health Sciences has launched GlaucoCetin, a supplement shown in a small clinical trial to positively affect the optic nerve cells in glaucoma patients.Created by Dr Robert Ritch of New York

New Zealander Steve Stenersen is the only southern hemisphere optician in the running for the 2019 IOA/Silmo Optician of the Year title to be announced at the annual Paris event this

All University of Auckland first year students can now take a general course in human vision.Convened by Associate Professor Sam Schwarzkopf, Professor Steven Dakin and Dr Misha Vorobyev, the new

FDA approval has been granted for Soliris injections to treat neuromyelitis optica spectrum disorder (NMOSD), an autoimmune disease of the central nervous system that affects the optic nerves and

Trials of a new acuity testing device have successfully increased health study participation rates among Māori.Dr Jason Turuwhenua, from Auckland University’s Bioengineering Institute and Ngāi Tūhoe

EssilorLuxottica intends to acquire full ownership of GrandVision ‘to create a truly global eyecare and eyewear company’, adding €3.7 billion to its annual revenue.The acquisition will see the global

The New Zealand Optical Wholesalers Association’s (NZOWA’s) future hangs in the balance after Gary Edgar reluctantly stepped down as president of the 40-year-old organisation with no one named to repl